Fluid Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Fluid Biotech's estimated annual revenue is currently $4.3M per year.
- Fluid Biotech's estimated revenue per employee is $155,000
Employee Data
- Fluid Biotech has 28 Employees.
- Fluid Biotech grew their employee count by 27% last year.
Fluid Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | VP, Business Development | Reveal Email/Phone |
3 | Senior Quality Engineer | Reveal Email/Phone |
4 | Quality Coordinator | Reveal Email/Phone |
Fluid Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 10% | N/A | N/A |
#2 | $4.3M | 56 | 8% | $1.7M | N/A |
#3 | $3M | 39 | 15% | N/A | N/A |
#4 | $4.2M | 54 | -4% | N/A | N/A |
#5 | $14.4M | 93 | 41% | N/A | N/A |
#6 | $4.5M | 29 | 26% | N/A | N/A |
#7 | $0.9M | 12 | -8% | N/A | N/A |
#8 | $3.7M | 24 | -17% | N/A | N/A |
#9 | $8.7M | 56 | -8% | $100K | N/A |
#10 | $3.3M | 21 | 62% | $13.4M | N/A |
What Is Fluid Biotech?
Fluid Biotech is a start-up located in Calgary, Alberta. The company is developing an innovative brain stent to heal aneurysms. It represents years of research work from the laboratories at the University of Calgary.
keywords:N/AN/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fluid Biotech News
Cellmax Life; Burning Rock Biotech; Berry Genomics Co; HaploX Biotechnology Co; New Horizon Health Limited; Genetronhealth; Amoy Diagnostics Co...
Instant Oral Fluid Testing Devices Market Size 2022-2029| Key Players Abbott Laboratories, AccuBioTech, Guangzhou Wondfo Biotech, MEDACX Ltd.
Insight CXR Triage analyzes scans for presuspected conditions, such as a critical build-up of fluid or a collapsed lung. It then alerts clinicians of urgent...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.8M | 28 | 27% | N/A |
#2 | $2.8M | 28 | N/A | N/A |
#3 | $4.3M | 28 | 17% | N/A |
#4 | $4.8M | 28 | 17% | N/A |
#5 | $2.9M | 29 | N/A | N/A |